Navigation Links
Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend
Date:11/1/2007

CO2) emission levels or taxes on CO2 emissions, that

result in increases in electric service costs could negatively impact

the corporation's net income, financial position and operating cash

flows if such costs cannot be recovered through rates granted by

ratemaking authorities in the states where the electric utility

provides service or through increased market prices for electricity.

-- The corporation's plans to grow and diversify through acquisitions may

not be successful and could result in poor financial performance.

-- The corporation's plan to grow its nonelectric businesses could be

limited by state law.

-- Competition is a factor in all of the corporation's businesses.

-- Economic uncertainty could have a negative impact on the corporation's

future revenues and earnings.

-- Volatile financial markets and changes in the corporation's debt rating

could restrict the corporation's ability to access capital and could

increase borrowing costs and pension plan expenses.

-- The price and availability of raw materials could affect the revenue

and earnings of the corporation's manufacturing segment.

-- The corporation's food ingredient processing segment operates in a

highly competitive market and is dependent on adequate sources of raw

materials for processing. Should the supply of these raw materials be

affected by poor growing conditions, this could negatively impact the

results of operations for this segment. This segment could also be

impacted by foreign currency changes between Canadian and United States

currency and prices of natural gas.

-- The corporation's plastics segment is highly dependent on a limited

number of vendors for PVC resin, many of which are located in the Gulf

Coast regions, and a limited supply of resin. The loss of a key ven
'/>"/>

SOURCE Otter Tail Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Cancer Patient Wins Lottery
2. UK’s Health Services Totterin
3. Virus Claims Harry Potter is Dead!
4. Potter and His Pals Light Up and Get Drunk Too!
5. Childline Gears Up for Distraught Potter Fans
6. Final Potter Book Already Out on the Web?
7. Harry Potter Final Book - Prediction and Expectations
8. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
9. PM announces a new health care order for India
10. Ramdoss Announces Introduction of RCH-II
11. Britain Announces Third Transfusion Related Mad Cow Case
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 1Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 2Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 3Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next Generation Everolimus Stent 14141 4ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 1ClariVein 28TM 29 Catheter for Varicose Veins 3A Further Clinical Trial Results to Be Presented 5019 2NewCardio Completes 242 9 Million Private Placement 57625 1NewCardio Completes 242 9 Million Private Placement 57625 2NewCardio Completes 242 9 Million Private Placement 57625 3NewCardio Completes 242 9 Million Private Placement 57625 4